GLP1 agonists set to become the best-selling drugs in 2024: GlobalData
Shift could reflect a changing demand away from oncology toward addressing metabolic disorders
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
Cagrisema
India is a key market for the company’s global plans
Vikrant Shrotriya, CVP & MD, Novo Nordisk India in an interaction with Express Pharma growth opportunities in pharma sector…